- Home
- SOPH vs NVCT Comparison
SOPH vs NVCT Comparison
Compare SOPH & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- NVCT
- Stock Information
- Founded
- SOPH 2011
- NVCT 2020
- Country
- SOPH Switzerland
- NVCT United States
- Employees
- SOPH N/A
- NVCT N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- SOPH Health Care
- NVCT Health Care
- Exchange
- SOPH Nasdaq
- NVCT Nasdaq
- Market Cap
- SOPH 206.6M
- NVCT 170.3M
- IPO Year
- SOPH 2021
- NVCT 2022
- Fundamental
- Price
- SOPH $3.32
- NVCT $9.77
- Analyst Decision
- SOPH Strong Buy
- NVCT Strong Buy
- Analyst Count
- SOPH 2
- NVCT 2
- Target Price
- SOPH $6.50
- NVCT $15.00
- AVG Volume (30 Days)
- SOPH 40.7K
- NVCT 128.5K
- Earning Date
- SOPH 03-04-2025
- NVCT 05-06-2025
- Dividend Yield
- SOPH N/A
- NVCT N/A
- EPS Growth
- SOPH N/A
- NVCT N/A
- EPS
- SOPH N/A
- NVCT N/A
- Revenue
- SOPH $65,173,000.00
- NVCT N/A
- Revenue This Year
- SOPH $16.63
- NVCT N/A
- Revenue Next Year
- SOPH $26.11
- NVCT N/A
- P/E Ratio
- SOPH N/A
- NVCT N/A
- Revenue Growth
- SOPH 4.49
- NVCT N/A
- 52 Week Low
- SOPH $2.70
- NVCT $4.44
- 52 Week High
- SOPH $6.28
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- SOPH 48.85
- NVCT 60.31
- Support Level
- SOPH $2.98
- NVCT $8.45
- Resistance Level
- SOPH $3.75
- NVCT $10.67
- Average True Range (ATR)
- SOPH 0.28
- NVCT 0.99
- MACD
- SOPH 0.05
- NVCT 0.08
- Stochastic Oscillator
- SOPH 44.08
- NVCT 72.98
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.